High-Dimensional Mediation Analysis: A New Method Applied to Maternal Smoking, Placental DNA Methylation, and Birth Outcomes.
Journal
Environmental health perspectives
ISSN: 1552-9924
Titre abrégé: Environ Health Perspect
Pays: United States
ID NLM: 0330411
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
medline:
18
4
2023
entrez:
14
4
2023
pubmed:
15
4
2023
Statut:
ppublish
Résumé
High-dimensional mediation analysis is an extension of unidimensional mediation analysis that includes multiple mediators, and increasingly it is being used to evaluate the indirect omics-layer effects of environmental exposures on health outcomes. Analyses involving high-dimensional mediators raise several statistical issues. Although many methods have recently been developed, no consensus has been reached about the optimal combination of approaches to high-dimensional mediation analyses. We developed and validated a method for high-dimensional mediation analysis (HDMAX2) and applied it to evaluate the causal role of placental DNA methylation in the pathway between exposure to maternal smoking (MS) during pregnancy and gestational age (GA) and birth weight of the baby at birth. HDMAX2 combines latent factor regression models for epigenome-wide association studies with HDMAX2 demonstrated increased power in comparison with state-of-the-art multidimensional mediation methods and identified several AMRs not identified in previous mediation analyses of exposure to MS on birth weight and GA. The results provided evidence for a polygenic architecture of the mediation pathway with a posterior estimate of the overall indirect effect of CpGs and AMRs equal to HDMAX2 outperformed existing approaches and revealed an unsuspected complexity of the potential causal relationships between exposure to MS and birth weight at the epigenome-wide level. HDMAX2 is applicable to a wide range of tissues and omic layers. https://doi.org/10.1289/EHP11559.
Sections du résumé
BACKGROUND
High-dimensional mediation analysis is an extension of unidimensional mediation analysis that includes multiple mediators, and increasingly it is being used to evaluate the indirect omics-layer effects of environmental exposures on health outcomes. Analyses involving high-dimensional mediators raise several statistical issues. Although many methods have recently been developed, no consensus has been reached about the optimal combination of approaches to high-dimensional mediation analyses.
OBJECTIVES
We developed and validated a method for high-dimensional mediation analysis (HDMAX2) and applied it to evaluate the causal role of placental DNA methylation in the pathway between exposure to maternal smoking (MS) during pregnancy and gestational age (GA) and birth weight of the baby at birth.
METHODS
HDMAX2 combines latent factor regression models for epigenome-wide association studies with
RESULTS
HDMAX2 demonstrated increased power in comparison with state-of-the-art multidimensional mediation methods and identified several AMRs not identified in previous mediation analyses of exposure to MS on birth weight and GA. The results provided evidence for a polygenic architecture of the mediation pathway with a posterior estimate of the overall indirect effect of CpGs and AMRs equal to
DISCUSSION
HDMAX2 outperformed existing approaches and revealed an unsuspected complexity of the potential causal relationships between exposure to MS and birth weight at the epigenome-wide level. HDMAX2 is applicable to a wide range of tissues and omic layers. https://doi.org/10.1289/EHP11559.
Identifiants
pubmed: 37058433
doi: 10.1289/EHP11559
pmc: PMC10104171
doi:
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
47011Références
Stat Med. 2019 Aug 15;38(18):3346-3360
pubmed: 31074092
Nucleic Acids Res. 2016 Feb 18;44(3):e20
pubmed: 26384415
Am J Epidemiol. 2019 Nov 1;188(11):1878-1886
pubmed: 31497855
Nat Commun. 2021 Aug 24;12(1):5095
pubmed: 34429407
BMC Bioinformatics. 2016 Jun 29;17:259
pubmed: 27358049
Bioinformatics. 2016 Oct 15;32(20):3150-3154
pubmed: 27357171
Ann Stat. 2017 Oct;45(5):1863-1894
pubmed: 31439967
Med Hypotheses. 2011 Nov;77(5):872-4
pubmed: 21864991
Bioinformatics. 2018 Jul 15;34(14):2418-2424
pubmed: 29420693
Front Immunol. 2016 Nov 17;7:510
pubmed: 27909437
Ann Hum Genet. 2004 May;68(Pt 3):196-204
pubmed: 15180700
PLoS One. 2012;7(6):e39791
pubmed: 22761903
Bioinformatics. 2013 Jan 15;29(2):189-96
pubmed: 23175756
BMC Med Genet. 2018 Sep 14;19(1):166
pubmed: 30217189
Psychol Methods. 2010 Dec;15(4):309-34
pubmed: 20954780
Environ Health Perspect. 2012 Oct;120(10):1425-31
pubmed: 22851337
Epigenomics. 2018 Mar 1;10(3):321-333
pubmed: 29381081
Epigenomics. 2017 Mar;9(3):253-265
pubmed: 28234025
Biometrika. 2017 Jun;104(2):303-316
pubmed: 29430031
Clin Epigenetics. 2016 Nov 16;8:118
pubmed: 27891191
BMC Genomics. 2011 Oct 28;12:529
pubmed: 22032438
PLoS One. 2015 Oct 28;10(10):e0141294
pubmed: 26510177
Am J Obstet Gynecol. 2015 Oct;213(4 Suppl):S14-20
pubmed: 26428494
Genes (Basel). 2017 Mar 18;8(3):
pubmed: 28335457
Environ Health Perspect. 2020 May;128(5):55001
pubmed: 32379489
Biom J. 2022 Aug;64(6):1090-1108
pubmed: 35426161
Front Genet. 2019 Nov 22;10:1195
pubmed: 31824577
Stat Appl Genet Mol Biol. 2022 Mar 07;21(1):
pubmed: 35245419
Clin Epigenetics. 2021 Mar 4;13(1):47
pubmed: 33663600
J Am Stat Assoc. 2022;117(537):198-213
pubmed: 35400115
Am J Physiol Heart Circ Physiol. 2016 May 15;310(10):H1295-303
pubmed: 26968548
Nat Methods. 2016 May;13(5):443-5
pubmed: 27018579
Placenta. 2016 Jul;43:81-5
pubmed: 27324104
J Pers Soc Psychol. 1986 Dec;51(6):1173-82
pubmed: 3806354
Annu Rev Public Health. 2016;37:17-32
pubmed: 26653405
Annu Rev Psychol. 2007;58:593-614
pubmed: 16968208
Environ Pollut. 2021 Dec 1;290:118024
pubmed: 34523531
Sci Rep. 2015 Sep 21;5:14107
pubmed: 26388242
Int J Epidemiol. 2015 Aug;44(4):1224-37
pubmed: 25862628
Environ Int. 2018 Sep;118:334-347
pubmed: 29935799
Int J Environ Res Public Health. 2021 May 11;18(10):
pubmed: 34064931
Mol Biol Evol. 2019 Apr 1;36(4):852-860
pubmed: 30657943
BMC Med. 2020 Oct 7;18(1):306
pubmed: 33023569
Nucleic Acids Res. 2021 Jan 8;49(D1):D325-D334
pubmed: 33290552
Nucleic Acids Res. 2021 Jan 8;49(D1):D545-D551
pubmed: 33125081
Epigenetics. 2014 Nov;9(11):1473-84
pubmed: 25482056
Placenta. 2020 Apr;93:56-63
pubmed: 32250740
Comput Struct Biotechnol J. 2021 May 26;19:3209-3224
pubmed: 34141140
Sci Adv. 2018 Jan 31;4(1):eaao4364
pubmed: 29399631
Int J Epidemiol. 2016 Oct;45(5):1644-1655
pubmed: 27591263
PLoS Genet. 2007 Sep;3(9):1724-35
pubmed: 17907809
Nucleic Acids Res. 2020 Jan 8;48(D1):D77-D83
pubmed: 31665515
BMC Bioinformatics. 2008 Jul 09;9:303
pubmed: 18613966
Nat Rev Genet. 2018 Feb;19(2):110-124
pubmed: 29225335
Int J Epidemiol. 2016 Apr;45(2):353-63
pubmed: 26283636